End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.29 CNY | -1.90% | -8.20% | -3.53% |
Business Summary
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Anti-infective Drugs
22.2
%
| 173 | 20.9 % | 177 | 22.2 % | +2.23% |
Urinary System Drugs
20.7
%
| 129 | 15.5 % | 165 | 20.7 % | +28.39% |
Other Medicines
17.0
%
| 119 | 14.4 % | 136 | 17.0 % | +13.61% |
Pediatric Use
8.4
%
| 70 | 8.4 % | 67 | 8.4 % | -3.42% |
Anti-allergy
8.3
%
| 166 | 20.1 % | 66 | 8.3 % | -60.22% |
Respiratory Medicine
7.2
%
| 39 | 4.7 % | 58 | 7.2 % | +47.77% |
Pharmaceutical Raw Materials and Intermediates
7.1
%
| 46 | 5.6 % | 57 | 7.1 % | +22.82% |
Service
3.3
%
| 34 | 4.1 % | 27 | 3.3 % | -20.84% |
Kidney Medicine
3.3
%
| 37 | 4.5 % | 26 | 3.3 % | -29.20% |
Health Food
1.6
%
| 11 | 1.3 % | 13 | 1.6 % | +16.91% |
Other Business
0.9
%
| 4 | 0.5 % | 7 | 0.9 % | +65.81% |
Commercial
0.1
%
| 0 | 0.1 % | 1 | 0.1 % | +71.18% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 807 | 97.3 % | 799 | 100.0 % | -0.93% |
Hong Kong
0.0
%
| 22 | 2.7 % | 0 | 0.0 % | -99.09% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Qun Zhao
CEO | Chief Executive Officer | 53 | 05-02-28 |
Yan Jie He
DFI | Director of Finance/CFO | 42 | 10-11-30 |
Hai Rong Zhong
BRD | Director/Board Member | 65 | 15-03-16 |
Jun Xian Yu
BRD | Director/Board Member | 57 | 05-02-28 |
Xu Hong Zhang
BRD | Director/Board Member | 53 | 05-02-28 |
Yuan Yuan Xue
IRC | Investor Relations Contact | - | - |
Ying Min Yu
PRN | Corporate Officer/Principal | 61 | 16-07-06 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Qun Zhao
CEO | Chief Executive Officer | 53 | 05-02-28 |
Xu Hong Zhang
BRD | Director/Board Member | 53 | 05-02-28 |
Jun Xian Yu
BRD | Director/Board Member | 57 | 05-02-28 |
Hai Rong Zhong
BRD | Director/Board Member | 65 | 15-03-16 |
Hao Gao
BRD | Director/Board Member | 54 | 20-02-10 |
Le Qun Huang
CHM | Chairman | 69 | 20-01-31 |
Tao Ju
BRD | Director/Board Member | 38 | 20-02-10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 241,618,563 | 182,672,525 ( 75.60 %) | 0 | 75.60 % |
Company contact information
Shanxi C&Y Pharmaceutical Group Co., Ltd.
1378, Heng'an Street Economic & Technological Dev Zone
037010, Datong
+
http://www.cy-pharm.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-3.53% | 311M | |
+35.01% | 709B | |
+30.67% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.79% | 239B | |
+9.52% | 211B | |
-3.84% | 203B | |
+10.77% | 171B |
- Stock Market
- Equities
- 300254 Stock
- Company ShanXi C&Y Pharmaceutical Group Co.,LTD.